"At Ophthalmology Associates, our goal is to provide you with the best possible care in a pleasant and efficient manner. This involves treating each patient as an individual with a unique set of circumstances and carefully educating the patient and family about the illness and its causes, as well as various diagnostic tests or treatment measures that are available."

During the past decade, Ophthalmology Associates conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 17 clinical trials were completed, i.e. on average, 58.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 12 clinical trials were completed. i.e. 85.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ophthalmology Associates" #1 sponsor was "Allergan" with 4 trials, followed by "Merck Sharp & Dohme LLC" with 4 trials sponsored, "Kala Pharmaceuticals, Inc." with 3 trials sponsored, "Cxlusa" with 2 trials sponsored and "Formosa Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ophthalmology Associates" #1 collaborator was "Bausch & Lomb Incorporated" with 2 trials as a collaborator, "Coopervision, Inc." with 1 trials as a collaborator, "Jaeb Center for Health Research" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator and "Ophthalmology Associates, St Louis" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Ophthalmology Associates" are "Dry Eye" (8 trials), "Dry Eye Syndromes" (7 trials), "Blepharitis" (5 trials), "Keratoconjunctivitis Sicca" (3 trials) and "Cataract" (2 trials). Many other conditions were trialed in "Ophthalmology Associates" in a lesser frequency.

Most popular intervention types in "Ophthalmology Associates" are "Drug" (36 trials), "Other" (5 trials), "Device" (3 trials), "Biological" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Vehicle" (3 trials), "APP13007, 0.05%" (2 trials), "Azithromycin ophthalmic solution, 1%" (2 trials) and "Dexamethasone" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ophthalmology Associates" are 44 trials for "All" genders.

Currently, there are NaN active trials in "Ophthalmology Associates". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 34 completed trials in Ophthalmology Associates, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Ophthalmology Associates, 4 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 4 trials that are defined as “Not Applicable".